Bradley L Campbell

FOLD

Bradley L Campbell serves as director, officer: President and CEO at Amicus Therapeutics, Inc. (FOLD). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

53 trades

$7.87M

Net Position

Net Seller

$7.87M

Companies Traded

FOLD

Active Period

Mar 2021 – Jan 2026

53 total trades

Most Recent

Sell FOLD

Jan 22, 2026 · $1.07M

Bradley L Campbell's Insider Trading at Amicus Therapeutics, Inc. (FOLD)

Buys

0 · $0.00

Sells

3 · $338.0K

Total Shares Bought

Total Shares Sold

31,542

FOLD Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
May 5, 2021	Sell	10,514	$10.27	$108.0K	412,022
Apr 5, 2021	Sell	10,514	$10.03	$105.5K	378,857
Mar 3, 2021	Sell	10,514	$11.84	$124.5K	378,857

Showing 51–53 of 53

Related Insiders

David Michael Clark

Chief People Officer

FOLDSell · Dec 23, 2025

Jeff Castelli

Chief Development Officer

FOLDSell · Nov 26, 2025

Ellen Rosenberg

Chief Legal Officer

FOLDSell · Nov 26, 2025

Explore More Insider Trading Data

FOLD Insider Trading Activity

View all insider trades at Amicus Therapeutics, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity